Stevens John, Firth Willow, Dooley Lynne, Longbottom Hayley, Wills Kalinda, Egger Garry, Morgan Bob
Australasian Society of Lifestyle Medicine (ASLM) and Discipline Lead Lifestyle Medicine, Southern Cross University (SCU), Lismore, NSW, Australia.
Waminda, South Coast Women's Aboriginal Health and Well-Being Organisation, Nowra, NSW, Australia.
Am J Lifestyle Med. 2025 Jan 8:15598276241312084. doi: 10.1177/15598276241312084.
First Nations women in Australia diagnosed with type 2 diabetes, co-designed and attended a programmed shared medical appointment that included continuous glucose monitors and culturally responsive food appreciation activities over 8 weekly sessions to improve glycaemic control. The project was a single site, longitudinal change from baseline, mixed methods, feasibility study using HbA1c as the primary outcome measure. Secondary outcome measures included, weight, metabolic health-related blood panels, CGM, Blood Glucose Levels (BGL) time-in-range percentage, Patient Activation Measure (PAM) and Problem Areas In Diabetes (PAID) tools and client satisfaction survey and semi focussed interviews. Forty participants commenced and twenty-five participants completed the program (62,5%). Of the completing participants the mean HbA1c had an absolute reduction of 0.7 percentage points ( from baseline to program completion, = .013). Eighteen (75%) reduced HbA1c and maintained some reduction for 12 months. Seven (28%) achieved remission, HbA1c <6.4% (46 mmol/l) maintained for 12 months. There were statistically significant improvements in weight, systolic blood pressure, liver enzymes, BGL time-in-range, PAM and PAID scores. It is feasible to use programmed shared medical appointments incorporating CGM aiming to improve glycaemic control and other metabolic measures of health among First Nations women in Australia. The project was registered with the Australian and New Zealand Clinical Trial Registry ACTRN12622000650796. https://www.anzctr.org.au/ACTRN12622000650796.aspx.
澳大利亚被诊断患有2型糖尿病的原住民女性共同设计并参加了一个计划性共享医疗预约项目，该项目包括连续血糖监测以及为期8周的具有文化适应性的食物鉴赏活动，以改善血糖控制。该项目是一项单中心、从基线开始的纵向变化、混合方法的可行性研究，以糖化血红蛋白（HbA1c）作为主要结局指标。次要结局指标包括体重、与代谢健康相关的血液指标、连续血糖监测、血糖水平（BGL）处于目标范围内的百分比、患者激活量表（PAM）、糖尿病问题领域（PAID）工具以及客户满意度调查和半聚焦访谈。40名参与者开始参加该项目，25名参与者完成了该项目（62.5%）。在完成项目的参与者中，平均糖化血红蛋白绝对降低了0.7个百分点（从基线到项目结束，P = 0.013）。18名（75%）参与者糖化血红蛋白降低，并在12个月内保持了一定程度的降低。7名（28%）实现缓解，糖化血红蛋白<6.4%（46 mmol/l）并维持12个月。体重、收缩压、肝酶、血糖处于目标范围内的时间、患者激活量表和糖尿病问题领域评分有统计学意义的改善。在澳大利亚原住民女性中，使用包含连续血糖监测的计划性共享医疗预约来改善血糖控制和其他健康代谢指标是可行的。该项目已在澳大利亚和新西兰临床试验注册中心注册，注册号为ACTRN12622000650796。https://www.anzctr.org.au/ACTRN12622000650796.aspx
